Several changes will take place at chemical company BASF. Next to changes in the Board of Directors the company transforms from a German entity into an European company.
In its meeting of July 6, 2007, the supervisory board of BASF
Aktiengesellschaft, in Ludwigshafen, Germany has appointed two new members to
the Board of Executive Directors: Dr. Harald Schwager (47) and Dr. Wolfgang
Büchele (48). The contracts of two current members of the Board of Executive
Directors – Dr. Kurt Bock (49) and Dr. Andreas Kreimeyer (52) – were extended
until the Annual Meeting in 2012.
As a result of these changes, the Board
of Executive Directors has decided to reassign responsibilities within the
Board.
Following the transformation of the German BASF Aktiengesellschaft
into a European Company, Societas Europaea (BASF SE), these changes will be made
stepwise until the Annual Meeting on April 24, 2008.
Effective August 1,
2007, the Board of Executive Directors (BED) has appointed Chief Financial
Officer Dr. Kurt Bock as Chairman and CEO of BASF Corporation in the United
States in addition to his current duties.
The new appointments to the
Board were necessary due to the retirement of three current members.
With the new appointments, the number of members of the
Board of Executive Directors will be reduced from nine to eight. The
responsibilities on the Board will be organized as follows and will be effective
at the conclusion of the Annual Meeting on April 24, 2008: